Fennec Pharmaceuticals, Inc. (FENC)
6.79
+0.49
(+7.78%)
USD |
NASDAQ |
Apr 17, 16:00
6.80
+0.01
(+0.15%)
After-Hours: 20:00
Fennec Pharmaceuticals Total Liabilities (Quarterly) : 35.10M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 53.49M |
| Gossamer Bio, Inc. | 295.01M |
| REGENXBIO, Inc. | 350.30M |
| Zymeworks, Inc. | 78.03M |
| Apellis Pharmaceuticals, Inc. | 705.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 70.58M |
| Shareholders Equity (Quarterly) | 35.47M |
| Current Ratio | 6.374 |
| Net Debt Paydown Yield | 2.26% |